Reply To:
Name - Reply Comment
.jpg)
Dr. Richard S. Rajapaksa
Unnecessary drugs for simple illnesses. Prescriptions of expensive brands of pharmaceuticals. Pointless laboratory tests. Unwarranted imaging such as CT and MRI. Needless medical procedures. “Diseases” that do not exist, but are “treated”. This is a world-wide phenomenon. All of which end up as profits of the pharmaceutical and medical devices industry.
It is big business. The estimated turnover of the twelve largest pharmaceutical companies in the world was around US$ 450 billion in 2010. The profit of these companies alone came to almost US$ 100 billion. They are rich. They are powerful. Are they ethical? Well …..
The New York Times and BBC reported on July 02, 2012 that one of the biggest companies on that rich-list pleaded guilty to criminal charges and agreed to pay a US$3 billion (yes, 3 billion!) for settlement of the largest health-care fraud case in the U.S. and the largest payment by a drug company.
The company pleaded guilty to the charges of illegal promotion of prescription of drugs, its failure to report safety data, bribing doctors, and promoting medicines for uses for which they were not licensed.
A US attorney, quoted by BBC stated that the sales force of this company bribed physicians to prescribe its products “using every imaginable form of high-priced entertainment, from Hawaiian vacations [and] paying doctors millions of dollars to go on speaking tours, to tickets to Madonna concerts”
Do you think that such things happen only in the United States of America? A popular Sinhala song comes to mind.
According to the US Department of Justice, the previous highest settlement was US$ 2.3 billion paid by an even larger pharmaceutical multinational in 2009. It pleaded guilty to charges of illegal promotion of several of its pharmaceutical products and paying kickbacks to healthcare providers to induce them to prescribe these products.
Last year, another giant multinational on the same rich-list pleaded guilty to criminal and civil charges, and paid US$ 1.5 billion. This company, among other things, had maintained a specialised sales force to market a drug using false claims, induced health care providers to use this drug and downplayed risks of the drug.
There are many other such examples. The enormity of the settlement amounts reflects the enormity of the crimes. Crimes for which the imposed fines were in billions of dollars. Can this not happen elsewhere? After all, all three companies operate in many other countries, including our own.
In Sri Lanka, currently, the pharmaceutical market is estimated to be worth around Rs. 50 billion annually. Assuming that the profit margins are the same as elsewhere, this year, the profit of this industry will be around Rs 10 billion. Yes, Rs. 10,000,000,000. Internationally, it is estimated that at around 20% of revenue is spent on marketing by the pharmaceutical industry. Some argue that this could be much higher.
However, if we take the 20% estimate, at least Rs. 10,000,000,000 is doing its rounds, “marketing” pharmaceuticals in Sri Lanka. In this context, “marketing” means things that an entity does to increase its sales and profits. As the examples from the US show, in this game, anything goes. That includes even Madonna concerts, in some instances. If so, will we, the general public stand a chance?
The agency responsible for regulation of pharmaceuticals in Sri Lanka is the Cosmetics, Devices and Drugs Regulatory Authority, which is under the Ministry of Health. Assuming its website in up to date, currently Sri Lanka can boast of over 8,800 registered pharmaceutical formulations.
This includes over 150 varieties of the anti-cholesterol drug Atorvastatin and the antibiotic Amoxicillin, almost 100 varieties of Metformin the anti-diabetic drug, over 100 varieties of Esomeprazole and around 80 varieties of Omeprazole, both medications for Gastritis, and over 70 varieties of Paracetamol and so on. Describing this as excessive will be an understatement.
Can the regulatory agency and the National Drug Quality Assurance Laboratory of the Ministry of Health be reasonably expected to assure quality of all the registered pharmaceutical drugs? It is likely that these two agencies are overwhelmed by the avalanche of products that it has to monitor.
Even under such trying circumstances, according to the regulatory agency website, no less than 66 drug formulations have been found to be of poor quality and have been removed from the market in Sri Lanka this year. There are many injectable drugs in this list, which we all know are given to severely ill patients. There were also eye drops, drugs for diabetes, hypertension, epilepsy, asthma heart disease, mental illnesses as well as antibiotics among them.
Many questions arise. Were you, your child, husband, wife, father, mother, brother or sister given these drugs before their dubious “quality” was discovered? Were there losses of life? How many suffered adverse reactions? How many had their illness and sufferings prolonged? How many other such “medicines” are out there right now? We will never know.
However, the answers to the following questions are certain. Will those who suffered be compensated? No chance. Will those responsible for releasing at least some of these on us ever be punished? No way.
So, we the public, are not only paying more for drugs, submitting ourselves to needless tests, being treated for non-existent conditions etc. etc., but also gobbling up and getting injected with dubious substances which we think are medicines.
| " In Sri Lanka, currently, the pharmaceutical market is estimated to be worth around Rs. 50 billion annually. Assuming that the profit margins are the same as elsewhere, this year, the profit of this industry will be around Rs 10 billion. Yes, Rs. 10,000,000,000. Internationally, it is estimated that at around 20% of revenue is spent on marketing by the pharmaceutical industry. Some argue that this could be much higher. " |